Drug Polymorphism Analysis

Drug Polymorphism Analysis is a spectroscopic methodology that identifies and characterizes the distinct crystalline forms of a pharmaceutical compound to assess their impact on drug stability, solubility, and bioavailability.

240

Publications

10.1K

Citations

876

Authors

333

Institutions

Publications per year

2017–2026

37

Authors

876

  1. AJ
    Adam J. Matzger

    University of Michigan, United States

    6 publications · 580 citations

    6

    h-index

  2. RC
    R. Céolin

    Laboratoire de Chimie Physique, France

    4 publications · 120 citations

    4

    h-index

  3. UJ
    Ulrich J. Griesser

    Universität Innsbruck, Austria

    4 publications · 295 citations

    4

    h-index

  4. TR
    Thomas Rades

    University of Copenhagen, Denmark

    4 publications · 208 citations

    4

    h-index

  5. JH
    J.-O. Henck

    Universität Innsbruck, Austria

    4 publications · 340 citations

    4

    h-index

1–5 of 876

Venues

  1. Crystal Growth & Design

    24 publications · 1.1K citations

    19

    h-index

  2. Journal of Pharmaceutical Sciences

    18 publications · 673 citations

    16

    h-index

  3. International Journal of Pharmaceutics

    14 publications · 682 citations

    14

    h-index

  4. Journal of Pharmacy and Pharmacology

    JPP · 12 publications · 279 citations

    11

    h-index

  5. 10

    h-index

1–5